Richard Martin

Richard Martin has extensive work experience in the pharmaceutical and biotechnology industry. Richard is currently the Vice President of Technical Operations at Travere Therapeutics, a position they have held since April 2017. Prior to this, they served as the Vice President of CMC and Head of Operations at Targazyme, Inc. from February 2016 to an unspecified end date. Before that, they were the Chief Development Officer at RetroVirox Inc. from May 2015 to February 2016. Martin also held the role of Vice President, Chemistry and Manufacturing at Apricus Biosciences, Inc. from March 2010 to January 2015. Richard served as the Director of Chemistry at Exelixis, Inc. from an unspecified start date to April 2009. Additionally, they were an Associate Director of Chemistry at X-Ceptor Therapeutics from an unspecified start date to an unspecified end date. Richard began their career as a Group Leader at Tanabe Research Labs from an unspecified start date to an unspecified end date.

Richard Martin completed a Bachelor's degree in Chemistry at Université Laval from 1989 to 1991. Richard then pursued a Ph.D. in Chemistry at the University of Toronto from 1991 to 1995. Following that, they completed a postdoctoral program in Chemistry at Scripps Research from 1995 to 1997.